Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a large drop in short interest during the month of May.
18 hours ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth · Care Delivery revenue increased by 2% (-1% at constant...
1 month ago

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced today that the U.S. Food and Drug Administration (FDA) designated...
4 weeks ago

Fresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a solid global...
1 week ago

Key abstract presentations showcase significant advancements in clinical care, artificial intelligence, and fluid management,...
2 weeks ago

World's largest dialysis specialist Fresenius Medical Care's first-quarter results beat market expectations across the board on Tuesday,...
1 month ago

Affected Product ... The FDA is aware that Fresenius Kabi USA has issued a letter to affected health care providers indicating a subset of Ivenix...
3 months ago

Fresenius Medical Care provides the most comprehensive product portfolio in dialysis. We continue to improve patient care in-center, at home, and in critical...
2 weeks ago

Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2...
1 week ago

The lawsuit seeks class status for all purchasers of outpatient dialysis services from DaVita, Fresenius or one of their affiliates. DaVita is...
1 month ago